Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
03/2012
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2432798A2 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases
03/28/2012EP1807065B1 Methods and compositions for treating nephrogenic diabetes insipidus
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN102395364A Pharmaceutical compositions
03/28/2012CN102395354A Microneedle array using porous substrate and process for producing same
03/28/2012CN102391304A 4-(2'-pyridine)-pyrimidine diperoxovanadate ammonium salt coordination compound and single crystal culture method and application thereof
03/28/2012CN102389539A Pure traditional Chinese medicine preparation for removing speckle and beautifying, and preparation method of pulvis and particle of the preparation
03/28/2012CN102389459A Traditional Chinese medicine composition for treating simple goiter
03/28/2012CN102389427A Solid oral preparation containing rosiglitazone and cetirizine hydrochloride
03/27/2012US8143424 Thyroid like compounds
03/27/2012US8143240 17α, 21-dihydroxypregnene esters as antiandrogenic agents
03/27/2012US8143216 For increasing plasma concentration of insulin-like growth factor-1; oximination with polyoxyethylene glycol
03/27/2012CA2421087C Antisense insulin-like growth factor binding protein (igfbp)-2 oligodeoxynucleotides for prostate and other endocrine tumor therapy
03/27/2012CA2389570C Methods for treating mild cognitive impairment
03/22/2012WO2012036233A1 Condensed heterocyclic derivative having melanine-concentrating hormone receptor antagonistic activity
03/22/2012WO2012035124A1 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071548 Therapeutic compositions
03/22/2012US20120071534 Lxr modulators
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071501 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
03/22/2012US20120071486 Thienopyrimidine compounds and use thereof
03/22/2012US20120071471 Novel benzoxazinone derivatives useful for the treatment of cns disorders
03/22/2012US20120071450 Organic compounds
03/22/2012US20120071401 Amylin agonist compounds for estrogen-deficient mammals
03/22/2012US20120070514 Aromatase inhibitor
03/22/2012US20120070444 IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERS
03/22/2012DE102010040924A1 Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung Substituted Phenylacet- and Phenylpropanamide and their use
03/21/2012EP2431355A1 New crystalline form vi of agomelatine, preparation method and application thereof
03/21/2012EP2431035A1 Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
03/21/2012EP2430018A2 Benzoxazolone derivatives as aldosterone symthase inhibitors
03/21/2012EP2429536A1 L-arabinose plus chromium for controlling the metabolization of sucrose
03/21/2012EP2429523A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
03/21/2012CN102388054A Thiazolopyridine sirtuin modulating compounds
03/21/2012CN102382075A Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
03/21/2012CN102379869A Oral preparation containing saxagliptin and application thereof
03/21/2012CN101628905B C-aryl glucoside sglt2 inhibitors and method
03/21/2012CN101426488B Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012US8138155 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/20/2012US8137689 Transplant/implant device and method for its production
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/20/2012CA2577497C 15.beta.-substituted steroids having selective estrogenic activity
03/20/2012CA2498167C Water-soluble polymer alkanals
03/20/2012CA2410901C Methods and compounds for controlled release of recombinant parvovirus vectors
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2396277C Condensed azepines as vasopressin agonists
03/20/2012CA2392453C Modulation of signal transduction
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012US20120065429 Water-soluble polymer alkanals
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065209 TETRAHYDRO-IMIDAZO[1,5-a]PYRAZINE DERIVATIVES SALTS, PREPARATION METHODS AND MEDICINAL USE THEREOF
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065131 Compositions and methods for topical application and transdermal delivery of an oligopeptide
03/15/2012US20120064166 Formulation comprising drospirenone for subcutaneous or intramuscular administration
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/14/2012EP2428516A1 Novel phosphorus-containing thyromimetics
03/14/2012EP2427215A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker
03/14/2012EP2240474B1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
03/14/2012CN102378757A Pyrimidine compound
03/14/2012CN102372756A Specific glucocorticosteroid compound having anti-inflammatory activity
03/14/2012CN102372722A C-aryl glucoside derivative, preparation method thereof and application of C-aryl glucoside derivative in medicine
03/14/2012CN102372701A Azabicyclo hexane derivative, preparation method, and application of azabicyclo hexane derivative in medicine
03/14/2012CN102372692A Dihydropyridine derivative
03/14/2012CN102370898A Chinese herbal medicine prescription for hyperthyroidism
03/14/2012CN102370877A Traditional Chinese medicinal composition for treating endocrine dyscrasia
03/14/2012CN102370748A Orally-taken drug for breast augmentation by traditional Chinese medicine
03/14/2012CN101272782B Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
03/13/2012CA2549824C Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/13/2012CA2356779C Cytokine receptor chain
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2011161427A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059012 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058938 Nutritional composition inducing a postprandial endocrine response
03/08/2012US20120058933 Synthetic peptides and peptide mimetics
03/08/2012US20120058176 Controlled release delivery system for nasal applications and method of treatment
03/08/2012US20120058128 Anti- integrin antibodies, compositions, methods and uses
03/08/2012US20120058089 Treatment of organ injuries and burns using placental stem cells
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/07/2012EP2426135A1 Urea derivative having pi3k inhibitory activity
03/07/2012EP2426117A1 Thiophene derivative
03/07/2012EP2425774A1 Model predictive method and system for controlling and supervising insulin infusion
03/07/2012EP2425773A1 Model predictive method and system for controlling and supervising insulin infusion
03/07/2012EP2425772A1 Model predictive method and system for controlling and supervising insulin infusion
03/07/2012EP2424865A2 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/07/2012EP2424861A1 Indole-2-carboxamide derivative
03/07/2012EP2424860A1 Heteroarylthiomethyl pyridine derivative
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012CN102369019A Fast-acting insulin formulation
03/07/2012CN102369018A Treatment of diabetes and metabolic syndrome
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 290